Details for New Drug Application (NDA): 018833
✉ Email this page to a colleague
NDA 018833 describes LITHANE, which is a drug marketed by Bayer Pharms and is included in one NDA. Additional details are available on the LITHANE profile page.
The generic ingredient in LITHANE is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
The generic ingredient in LITHANE is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
Summary for 018833
| Tradename: | LITHANE |
| Applicant: | Bayer Pharms |
| Ingredient: | lithium carbonate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018833
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
| Approval Date: | Jul 18, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
